Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialEugenio Mercuri, A. Nascimento, Giacomo P. Comi et al.|The Lancet Neurology|2024Cited by 128
Clinical trials of disease-modifying agents in pediatric MSEmmanuelle Waubant, Rinze F. Neuteboom, Lucia Moiola et al.|Neurology|2019Cited by 77
MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvementSandra Donkervoort, Timothy E. Shutt, Rasha Sabouny et al.|Acta Neuropathologica|2019Cited by 51
Life-Saving Treatments for Spinal Muscular AtrophyVictor Diego Armengol, Bhaskar Roy, Basil T. Darras et al.|Neurology Clinical Practice|2023Cited by 19
Lifesaving Treatments for Spinal Muscular Atrophy: Global Access and Availability (P5-4.003)Victor Diego Armengol, Bhaskar Roy, Basil T. Darras et al.|Neurology|2024Cited by 0